New Decision Science Doctoral Students

Composite image of S. Skye Yoden (top left) and Jessica Preston Harvey (bottom right) on an abstract background

Skye Yoden and Jessica Preston Harvey join the PhD Program in Health Policy, decision science track in Fall, 2023.

Skye Yoden graduated from the University of Pennsylvania with a BS in Economics and BA in Psychology and International Studies in 2008. Yoden received a Global Executive MBA from INSEAD in 2014. As Executive Director of Digital Square at PATH, Yoden expanded digital interventions to increase health equity. Yoden’s research interests include how individuals and institutions weigh immediate versus long-term costs and benefits of health interventions.

Jessica Preston Harvey received an MPH and a BS in Biomedical Engineering from the University of Virginia in 2018. Prior to joining the PhD program, Harvey worked as a research analyst at Advisory Board (now part of Optum / UnitedHealth Group) and as a consultant at IQVIA. Harvey’s research interests include investigating methods to assess the value of new drugs and devices, and exploring how our evolving understanding of a treatment’s value can and should impact our regulatory assessments, post-approval evidence requirements, pricing, access, and payment models.

Learn more: Visit the Doctoral Program page on the CHDS website
Learn more: Meet our PhD students

Read more: John Giardina Defends Dissertation
Read more: CHDS at 2023 Benefit-Cost Conference